Edition:
India

People: BioXcel Therapeutics Inc (BTAI.OQ)

BTAI.OQ on NASDAQ Stock Exchange Capital Market

10.59USD
9:22pm IST
Change (% chg)

$0.55 (+5.48%)
Prev Close
$10.04
Open
$9.89
Day's High
$10.97
Day's Low
$9.89
Volume
3,619
Avg. Vol
11,360
52-wk High
$14.28
52-wk Low
$2.41

Mehta, Vimal 

Mr. Vimal Mehta, Ph.D. is President, Chief Executive Officer, Secretary, Director of the Company. He is a co-founder of BioXcel Corporation and has served as its Chairman of the Board since 2005 and its Chief Executive Officer since September 2014. Dr. Mehta has held various senior scientific and business development positions, including Senior Vice President of Business Development at London-based Inpharmatica Ltd, a global predictive informatics company, from 2002 to 2006 and Senior Vice President, Business Development for Jubilant Life Sciences, an integrated global pharmaceutical and life sciences company, from 2006 to 2007. Previously, Dr. Mehta served as Business Development Manager at CuraGen Corporation, a biotechnology company, from 1996 to 2002. He held multiple positions in the Department of Radiology at the University of Texas, Southwestern Medical Center from 1989 to 1996, including Postdoctoral Fellow, Instructor and Assistant Professor. Dr. Mehta holds a Ph.D. in Chemistry from the University of Delhi, India and completed a Post-Doctoral Fellowship in Chemistry at the University of Montpellier, France.

Basic Compensation

Total Annual Compensation, USD 147,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 136,531
Fiscal Year Total, USD 283,531

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --